Project Grant K24HL179471
Award Date
7/10/25
Completion Date
4/30/30
Dollars Obligated
$130K
Federal Agency
National Heart Lung and Blood Institute
Federal Grant Program
93.837
Assistance Type
Project Grant
Place of Performance
San Francisco, CA 94110, USA
Similar Awards
This federal Project Grant award, funded by the National Heart, Lung, and Blood Institute (NHLBI) under the Cardiovascular Diseases Research program (CFDA 93.837), will support the development of a telemedicine intervention to improve hypertension management for Black patients. The $156,576 award, with a period of performance from September 1, 2024 to August 31, 2029, will be used by the prime awardee, Wake Forest University Health Sciences, to tailor a telemedicine-based hypertension management...
This Project Grant award from the National Heart, Lung, and Blood Institute (NHLBI), under the Cardiovascular Diseases Research program (CFDA 93.837), will provide $191,777 to the University of California, Davis to develop a personalized approach for determining optimal blood pressure targets. The project aims to: 1) Refine predictive models for individual-level changes in cardiovascular disease risk with intensive vs. standard blood pressure lowering; 2) Characterize patient preferences for...
This Project Grant award from the National Heart, Lung, and Blood Institute (NHLBI), under CFDA Program 93.837 Cardiovascular Diseases Research, provides $1,410,766 to the University of Florida to conduct a mixed methods comparative effectiveness analysis on the utilization and impact of telehealth and home blood pressure monitoring technologies during the COVID-19 pandemic. The project aims to: 1) evaluate trends and disparities in telehealth and home monitoring utilization, 2) estimate the...
This federal Project Grant award from the National Heart, Lung, and Blood Institute (CFDA 93.837 - Cardiovascular Diseases Research) provides $362,250 to Cleveland Clinic Lerner College of Medicine of Case Western Reserve University to evaluate whether treating elevated blood pressure in the inpatient setting impacts patient outcomes. The project, titled "Evaluating Whether Treating Elevated Blood Pressure in the Inpatient Setting Impacts Patient Outcomes: The ACT-BP Pilot," aims to...
The National Heart, Lung, and Blood Institute (NHLBI) awarded a $1,321,108 Project Grant under CFDA 93.837 (Cardiovascular Diseases Research) to New York University School of Medicine to conduct transdisciplinary implementation research on a strategy called PT4A. PT4A integrates peer-based medication delivery, peer coaching, and health information technology to improve medication adherence and reduce blood pressure among patients with uncontrolled hypertension in Western Kenya. The study aims to...
This Project Grant award from the National Heart, Lung, and Blood Institute (CFDA 93.837 - Cardiovascular Diseases Research) provides $165,364 to The Broad Institute, Inc. to conduct research focused on integrating novel contextual and genomic blood pressure measures to enhance cardiovascular disease prediction and management in young adults aged 18-39 years. The key objectives of this 2-year project are to: 1) identify novel ambulatory blood pressure patterns that capture dynamic responses to...
This $347,386 Project Grant, awarded by the National Science Foundation (NSF) under the Engineering program (CFDA 47.041), aims to develop a novel wearable device for continuous, cuffless blood pressure monitoring. The goal is to create an accurate, inexpensive, and easy-to-use technology to help manage hypertension and reduce hospitalizations associated with this condition. The approach leverages bioimpedance sensing in conjunction with physiological, computational, and machine learning...
This Project Grant award of $2,340,322, provided by the National Heart, Lung, and Blood Institute (NHLBI) under the Cardiovascular Diseases Research program (CFDA 93.837), will fund a prospective, multicenter cohort study of 1,268 liver transplant recipients (LTRs) over 2 years, with outcomes tracked up to 5 years post-transplant. The study aims to: Determine the net clinical benefit of blood pressure-lowering on target organs in LTRs, Evaluate if cardiac biomarker levels can improve...
This $132,410 Project Grant award from the National Heart, Lung, and Blood Institute (NHLBI) under the Cardiovascular Diseases Research program (CFDA 93.837) will provide protected time for Dr. Cheryl Anderson, a mid-career clinical investigator, to recruit and mentor a diverse group of trainees in clinical cardiovascular epidemiology and health equity research. The award will support two new areas of research: 1) integrating global policy and strategy into multilevel interventions to improve...
This Project Grant award from the National Heart, Lung, and Blood Institute (NHLBI), funded under the Cardiovascular Diseases Research program (CFDA 93.837), will support a $198,936 research project conducted by New York University School of Medicine. The project aims to investigate the impact of restrictive drug coverage policies, such as cost-sharing and prior authorization requirements, on prescribing patterns, medication adherence, and clinical outcomes for patients with heart failure with...